Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Pharmaceuticals
Teva Scholars Selected
by Linda Wang
August 13, 2012
| A version of this story appeared in
Volume 90, Issue 33
The American Chemical Society has announced the recipients of the Teva Pharmaceuticals Scholars grants, designed to support academic scientists at Ph.D.-granting institutions in the U.S. who are within four years of their first tenure decision. Awardees receive $100,000 per year for three years to support research with potential or direct connections to medicinal chemistry.
The awardees are Phil S. Baran of Scripps Research Institute; John J. Lavigne of the University of South Carolina, Columbia; and Ming Xian of Washington State University, Pullman.
Linda Wang compiles this section. Announcements of awards may be sent to l_wang@acs.org.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X